Harry Sacks

1.3k total citations
71 papers, 791 citations indexed

About

Harry Sacks is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harry Sacks has authored 71 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Physiology, 25 papers in Immunology and Allergy and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harry Sacks's work include Asthma and respiratory diseases (30 papers), Allergic Rhinitis and Sensitization (25 papers) and Sinusitis and nasal conditions (14 papers). Harry Sacks is often cited by papers focused on Asthma and respiratory diseases (30 papers), Allergic Rhinitis and Sensitization (25 papers) and Sinusitis and nasal conditions (14 papers). Harry Sacks collaborates with scholars based in United States, United Kingdom and France. Harry Sacks's co-authors include William J. Wheeler, Frank C. Hampel, N. Amar, Julius van Bavel, Paul H. Ratner, William E. Berger, Jonathan A. Bernstein, Piyush M. Patel, Steven W. Brostoff and Irving J. Slotnick and has published in prestigious journals such as JAMA, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Harry Sacks

62 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry Sacks United States	16	420	399	164	84	79	71	791
Dahlén Se Sweden	13	584 1.4×	152 0.4×	18 0.1×	418 5.0×	100 1.3×	30	820
Makoto Kudo Japan	5	245 0.6×	56 0.1×	90 0.5×	174 2.1×	281 3.6×	8	639
Bart G. J. Dekkers Netherlands	22	639 1.5×	136 0.3×	51 0.3×	535 6.4×	328 4.2×	46	1.4k
A. Gulbenkian United States	11	280 0.7×	141 0.4×	28 0.2×	94 1.1×	159 2.0×	23	599
Daichi Utsumi Japan	13	87 0.2×	19 0.0×	69 0.4×	137 1.6×	135 1.7×	21	487
Piper Pj United Kingdom	13	401 1.0×	88 0.2×	9 0.1×	272 3.2×	159 2.0×	43	1.0k
Tsugio Nakazawa Japan	21	361 0.9×	110 0.3×	46 0.3×	213 2.5×	491 6.2×	49	1.2k
Birgit Jung Germany	15	155 0.4×	32 0.1×	13 0.1×	237 2.8×	189 2.4×	23	697
Tatsuro Nakamura Japan	16	143 0.3×	113 0.3×	18 0.1×	77 0.9×	250 3.2×	45	764
Stephen L. Underwood United Kingdom	12	292 0.7×	75 0.2×	19 0.1×	222 2.6×	171 2.2×	16	588

Countries citing papers authored by Harry Sacks

Since Specialization

Citations

This map shows the geographic impact of Harry Sacks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Sacks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Sacks more than expected).

Fields of papers citing papers by Harry Sacks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Sacks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Sacks. The network helps show where Harry Sacks may publish in the future.

Co-authorship network of co-authors of Harry Sacks

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Sacks. A scholar is included among the top collaborators of Harry Sacks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Sacks. Harry Sacks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Porsbjerg, Celeste, Eleanor M. Dunican, Njira Lugogo, et al.. (2025). Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial. American Journal of Respiratory and Critical Care Medicine. 212(2). 241–252.

Washko, George R., et al.. (2025). Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE. Journal of Allergy and Clinical Immunology. 156(5). 1209–1218. 2 indexed citations

Fokkens, Wytske J., Claus Bachert, Claire Hopkins, et al.. (2024). Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial. Clinical & Translational Immunology. 13(6). e1511–e1511. 2 indexed citations

Phipatanakul, Wanda, Christian Vogelberg, Leonard B. Bacharier, et al.. (2024). Dupilumab 200 mg was efficacious in children (6–11 years) with moderate‐to‐severe asthma for up to 2 years: EXCURSION open‐label extension study. Pediatric Pulmonology. 59(11). 2976–2983. 2 indexed citations

Pavord, Ian, Celeste Porsbjerg, Mario Castro, et al.. (2024). ASSESSING THE IMPACT OF ASTHMA CONTROL QUESTIONNAIRE SCORE CUTOFFS WITHIN THE MULTICOMPONENT CLINICAL REMISSION ENDPOINT ON CLINICAL OUTCOMES: TRAVERSE OPEN-LABEL STUDY. CHEST Journal. 166(4). A4797–A4800. 1 indexed citations

Bachert, Claus, Asif Khan, Wytske J. Fokkens, et al.. (2024). Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP. Journal of Allergy and Clinical Immunology. 154(6). 1442–1449. 3 indexed citations

Lane, Andrew P., Joaquim Mullol, Claire Hopkins, et al.. (2024). Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia. Current Medical Research and Opinion. 41(1). 53–59. 1 indexed citations

Palmer, James N., Nithin D. Adappa, Rakesh K. Chandra, et al.. (2024). Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2). The Journal of Allergy and Clinical Immunology In Practice. 12(4). 1049–1061. 7 indexed citations

Wechsler, Michael E., Linda Rogers, Giorgio Walter Canonica, et al.. (2024). Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics. ERJ Open Research. 10(6). 188–2024.

10.

Busse, William W., Monica Kraft, Christian Domingo, et al.. (2024). Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Patients With Type 2 Asthma Irrespective of Asthma Duration. A5367–A5367. 1 indexed citations

11.

Papadopoulos, Nikolaos G., et al.. (2024). Type 2 Inflammation and Asthma in Children: A Narrative Review. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2310–2324. 12 indexed citations

12.

Ow, Randall A., John P. McGinnis, Harry Sacks, & Mark E. Mehle. (2022). The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps. Ear Nose & Throat Journal. 104(2). 93–101. 3 indexed citations

13.

Sacks, Harry, et al.. (2021). EDS-FLU (Exhalation Delivery System With Fluticasone) is Associated With Improved Sleep in Patients With Nasal Polyposis. Journal of Allergy and Clinical Immunology. 147(2). AB172–AB172.

14.

Hampel, Frank C., Paul H. Ratner, Julius van Bavel, et al.. (2010). Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Annals of Allergy Asthma & Immunology. 105(2). 168–173. 93 indexed citations

15.

Simon, Steve, et al.. (2010). Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study. Current Therapeutic Research. 71(1). 50–59. 6 indexed citations

16.

Ratner, Paul H., Frank C. Hampel, Julius van Bavel, et al.. (2008). Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 100(1). 74–81. 90 indexed citations

17.

Sacks, Harry, et al.. (2007). Fluorofelbamate. Neurotherapeutics. 4(1). 97–101. 22 indexed citations

18.

Berger, William E., Frank C. Hampel, Jonathan A. Bernstein, et al.. (2006). Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 97(3). 375–381. 43 indexed citations

19.

Corren, Jonathan, William W. Storms, Jonathan A. Bernstein, et al.. (2005). Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clinical Therapeutics. 27(5). 543–553. 56 indexed citations

20.

Bhat, Abdul, Harry Sacks, John A. Osborne, & Allan M. Lefer. (1989). Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats. American Heart Journal. 117(4). 799–803. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact